Endovascular Treatment of Medium-Vessel-Occlusion Strokes
Published May 13, 2026
N Engl J Med 2026;394:1894-1904
DOI: 10.1056/NEJMoa2514120
Abstract
Background
Endovascular thrombectomy for acute ischemic stroke due to medium-vessel occlusion has had varying results across trials. Whether thrombectomy improves functional outcomes in patients with medium-vessel occlusion and moderate-to-severe deficits is unclear.
Methods
We conducted an open-label, randomized trial with blinded outcome assessment at 48 centers in China. Eligible patients were adults who presented within 24 hours after the onset of a moderate-to-severe stroke (National Institutes of Health Stroke Scale [NIHSS] score, ≥6; scale, 0 to 42, with higher scores indicating greater neurologic deficits) due to occlusion of a medium vessel. Patients were assigned in a 1:1 ratio to thrombectomy plus medical management (thrombectomy group) or medical management alone (control group). The primary outcome was functional disability as measured by the shift in the modified Rankin scale score (scale, 0 [no disability] to 6 [death]) at 90 days. Violation of the proportional-odds assumption precluded the use of shift in the modified Rankin scale score, so as prespecified, functional independence (modified Rankin scale score of 0, 1, or 2) at 90 days was used as the primary outcome. Safety outcomes were symptomatic intracranial hemorrhage and 90-day mortality.
Results
Among 280 patients in the thrombectomy group and 283 in the control group, the median age was 71 years, the median NIHSS score was 10 (range, 3 to 36), and 42.8% were women; 36.6% received intravenous thrombolysis. Functional independence at 90 days was seen in 58.6% of the patients in the thrombectomy group and in 46.6% of those in the control group (adjusted rate ratio, 1.24; 95% confidence interval, 1.07 to 1.44; P=0.004). The incidence of symptomatic intracranial hemorrhage was 4.7% in the thrombectomy group and 2.2% in the control group; 90-day mortality was 11.1% and 10.2%, respectively.
Conclusions
Among patients with acute ischemic stroke due to medium-vessel occlusion and moderate-to-severe deficits, thrombectomy led to a greater likelihood of functional independence than medical management alone but also to a higher risk of symptomatic intracranial hemorrhage. (Funded by the National Natural Science Foundation of China and the Noncommunicable Chronic Diseases–National Science and Technology Major Project; ORIENTAL-MeVO ClinicalTrials.gov number, NCT06146790.)
Are you a member of an institution such as a university or hospital?Learn more about Institutional Access
Notes
A data sharing statement provided by the authors is available with the full text of this article at NEJM.org.
Supported by a grant (82471311) from the National Natural Science Foundation of China and by the Noncommunicable Chronic Diseases–National Science and Technology Major Project (2024ZD0527903).
Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
Supplementary Material
Information & Authors
Information
Published In
Copyright
Copyright © 2026 Massachusetts Medical Society. All rights reserved.
For personal use only. Any commercial reuse of NEJM Group content requires permission.
History
Published online: May 13, 2026
Published in issue: May 14, 2026
Topics
- Cardiology General
- Clinical Medicine General
- Critical Care
- Emergency Medicine General
- Geriatrics/Aging General
- Hospital-Based Clinical Medicine
- Neurology/Neurosurgery General
- Peripheral Arterial and Aortic Disease
- Pulmonary/Critical Care General
- Radiology General
- Stroke (Emergency Medicine)
- Stroke (Neurology/Neurosurgery)
Authors
Metrics & Citations
Metrics
Altmetrics
Citations
Export citation
Select the format you want to export the citation of this publication.
Cited by
- Endovascular Therapy for Medium-Vessel Occlusion Stroke — Narrowing the Target Population, New England Journal of Medicine, 394, 19, (1955-1957), (2026)./doi/full/10.1056/NEJMe2601852
Loading...
Facts Only
* The study included 280 patients in the thrombectomy group and 283 patients in the control group.
* The patients presented within 24 hours of a moderate-to-severe stroke (NIHSS score ≥6) due to medium-vessel occlusion.
* The primary outcome was functional independence (mRS score of 0, 1, or 2) at 90 days.
* Functional independence was observed in 58.6% of the thrombectomy group and 46.6% of the control group.
* The adjusted rate ratio for functional independence was 1.24 (95% CI, 1.07 to 1.44; P=0.004).
* The thrombectomy group had a symptomatic intracranial hemorrhage incidence of 4.7%.
* The control group had a symptomatic intracranial hemorrhage incidence of 2.2%.
* The median age of patients was 71 years.
* 36.6% of patients in the thrombectomy group received intravenous thrombolysis.
Executive Summary
Full Take
Sentinel — Human
This is a highly structured medical abstract presenting specific, methodologically detailed findings from a clinical trial, exhibiting the characteristics of professionally written scientific literature.
